Pediatrix Medical Group
S&P 600
$26.77
+0.15%
Delayed · cached 15 min
Fair value analysis
MD
Pediatrix Medical Group
$26.77
Close used for this calculation
$32.25Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
50/100
Quality radar
Consensus fair value
$32.25
Below FV▲ +20.5% against the close used
Model range $13.23 – $38.80
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$13.23Fair value$32.25Bull$38.80
FairClose
52-week traded range
52W low $15.8052W high $27.39
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Pediatrix Medical Group closed at $26.77, 17.0% below the consensus fair value of $32.25 drawn from 8 valuation models.
Financial DNA score 50/100 — Good. P/E of 13.8x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$36.36
+35.8%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
$21.75
-18.8%
√(22.5 × EPS × BVPS)
EPS=1.94, BVPS=10.84 · outside Graham range (P/E 13.8, P/B 2.5) — asset-light, treat as a rough floor
P/E Fair Value
$38.80
+44.9%
EPS × 20x (sector P/E)
EPS=1.94, Sector P/E=20x
Peter Lynch (PEG)
$13.23
-50.6%
EPS × Growth% (PEG = 1 is fair)
EPS=1.94, g=6.8%
EV/EBITDA
$27.05
+1.1%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=230.64M
Book Value (P/B)
$24.42
-8.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=10.84, ROE=18.8%, g=3%, r=10%
Reverse DCF
$26.77
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 2.1% | Historical: -6.8%
Margin of Safety
$24.23
-9.5%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=32.3, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.